URL copied to clipboard

Trending News

Mankind Pharma Surges 5% on ₹771 Crore Block Deal

Mankind Pharma shares jumped over 5% as the company saw a block deal for 0.9% stake at ₹2,061 per share. The strong market response reflects investor confidence in the pharmaceutical firm.
Mankind Pharma Surges 5% on ₹771 Crore Block Deal

Mankind Pharma, a leading domestic pharmaceutical firm, saw its stock price surge up to 5.27% in Wednesday’s intraday trade. This came after a block deal involving around 3.7 million shares, equivalent to a 0.9% stake, was executed at Rs 2,061 per share.

The likely seller in the block deal is Capital Group affiliate Hema CIPEF, which previously held a 2.22% stake in Mankind Pharma. The deal size was around Rs 771 crore.

Mankind Pharma is known for its diverse range of healthcare products, including antibiotics, gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications. The company has a strong presence in the domestic market.

In the March quarter of FY24, Mankind Pharma reported a 65.1% year-on-year rise in net profit to Rs 471.2 crore. The company’s revenue also grew by 19% to Rs 2,441.1 crore, with EBITDA surging by 41.8%.

The strong financial performance and the block deal have boosted investor sentiment, leading to a 2.12% intraday gain in Mankind Pharma’s stock price, even as the broader market benchmark Sensex fell by 1.01%.

Loading
Read More News
शीर्ष प्रदर्शन करने वाले: Vedanta और 9 अन्य स्टॉक्स ने इस सप्ताह शानदार प्रदर्शन किया!

शीर्ष प्रदर्शन करने वाले: Vedanta और 9 अन्य स्टॉक्स ने इस सप्ताह शानदार प्रदर्शन किया!

दिसंबर 2024 के शीर्ष स्टॉक्स को जानें, जिसमें उच्च प्रदर्शन करने वाले शेयरों, प्रभावी निवेश रणनीतियों, और आपके निवेश

Purple United Sales IPO तीसरे दिन 148.90x सब्सक्रिप्शन के साथ बढ़ा – पूरी जानकारी यहां देखें

Purple United Sales IPO ने तीसरे दिन 148.90x विशाल सब्सक्रिप्शन के साथ समाप्त – पूरी जानकारी प्राप्त करें!

Purple United Sales IPO ने तीसरे दिन 148.90x की प्रभावशाली सब्सक्रिप्शन प्राप्त की, जो मजबूत मांग, सकारात्मक बाजार भावना, और